2nd Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$990,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 21, 2025 $990,000 Replaced
2nd Quarter - Amendment Mar 10, 2026 $990,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax and tariffs Issues related to Intellectual Property Issues related to Inflation Reduction Act

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
CHRISTOPHER CUNNINGHAM —
BILL DAVIS —
SARAH ELIZABETH NORDSTROM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025 Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act Issues related to Most Favored Nation Proposals

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
CHRISTOPHER CUNNINGHAM —
SARAH ELIZABETH NORDSTROM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1492 (119th), S. 832 (119th)

Animals ANI

Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)

LobbyistCovered position, as disclosed
SCOTT BENNETT —
BILL DAVIS —

Contacted: Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3419 (119th), H.R. 8467 (119th), S. 1666 (119th)

Budget/Appropriations BUD

Issues related to FY2026 Appropriations

LobbyistCovered position, as disclosed
SCOTT BENNETT —
KATHARINE TROLLER BOND —
CHRISTOPHER CUNNINGHAM —
BILL DAVIS —
SARAH ELIZABETH NORDSTROM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Agriculture, Dept of (USDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.